Sustained release veterinary parenteral products.
Controlled release parenteral dosage forms have application in veterinary medicine. Systems that minimize the need for repeated injections while achieving therapeutic effects for extended periods offer benefits that make commercial development of these products desirable. While some products have already found commercial success, others will result from application of new controlled release technologies. This review highlights the formulation and technology challenges in developing some of these controlled release technologies into products. Further, examples of application of controlled release technologies in the veterinary field are discussed.
Medlicott
Natalie J
NJ
School of Pharmacy, University of Otago, P.O. Box 913, Dunedin, New Zealand. natalie.medlicott@stonebow.otago.ac.nz
Waldron
Niki A
NA
Foster
Todd P
TP
D000820:Animal Diseases / Q000188:drug therapy; D000818:Animals; D002626:Chemistry, Pharmaceutical; D003102:Colloids; D003692:Delayed-Action Preparations; D004343:Drug Implants; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D019999:Pharmaceutical Solutions; D019155:Veterinary Drugs / Q000008:administration & dosage* / Q000737:chemistry*
D003102:Colloids; D003692:Delayed-Action Preparations; D004343:Drug Implants; D019999:Pharmaceutical Solutions; D019155:Veterinary Drugs